PDF(Pubmed)
Abstract：
Despite considerable evidence for the benefit in chronic obstructive pulmonary disease (COPD), the implementation of pulmonary rehabilitation (PR) is insufficient. However, music therapy may help address this gap due to its unique benefits. Therefore, we aimed to develop a music-therapy facilitated pulmonary telerehabilitation program based on rhythm-guided walking, singing, and objective telemonitoring. A supervised, parallel-group, single-blinded, randomized controlled clinical trial will be conducted, including 75 patients with COPD anticipated to be randomized in a 1:1:1 ratio into three groups. The intervention groups will receive a 12-week remotely monitored rehabilitation program, while the usual care group will not receive any rehabilitation interventions. Of the two intervention groups, the multi-module music therapy group will contain rhythm-guided walking and singing training, while the rhythm-guided walking group will only include music tempo-guided walking. The primary outcome is the distance of the incremental shuttle walking test. Secondary outcomes include respiratory muscle function, spirometry, lower extremity function, symptoms, quality of life, anxiety and depression levels, physical activity level, training adherence, and safety measurements. The results of this study can contribute to develop and evaluate a home-based music-facilitated rehabilitation program, which has the potential to act as a supplement and/or substitute (according to the needs) for traditional center-based PR in patients with stable COPD. Clinical trial registration: https://classic.clinicaltrials.gov/, NCT05832814.
摘要：
尽管有大量证据表明慢性阻塞性肺疾病（COPD）的益处，肺康复（PR）的实施不足。然而,音乐疗法可能有助于解决这一差距，由于其独特的好处。因此,我们的目标是开发一种基于节奏引导步行的音乐疗法促进肺远程康复计划，唱歌,和客观的远程监测。有监督的，平行组，单盲,将进行随机对照临床试验，包括75例COPD患者,预计以1:1:1的比例随机分为三组.干预小组将接受为期12周的远程监控康复计划，而常规护理组不会接受任何康复干预。在两个干预组中，多模块音乐疗法小组将包括节奏指导的步行和唱歌训练，而节奏引导步行组将只包括音乐节奏引导步行。主要结果是递增穿梭行走测试的距离。次要结果包括呼吸肌功能，肺活量测定,下肢功能,症状,生活质量,焦虑和抑郁水平，身体活动水平,训练坚持，和安全措施。这项研究的结果可以有助于开发和评估基于家庭的音乐促进康复计划，它有可能（根据需要）作为稳定期COPD患者传统中心PR的补充和/或替代。临床试验注册：https://classic。clinicaltrials.gov/,NCT05832814。
